comparative effectiveness of semaglutide and tirzepatide vs bariatric surgery A network meta-analysis backed weight-loss benefits with several GLP-1 receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Semaglutide vs Tirzepatide for Weight

Retatrutide is a triple incretin receptor agonist (GLP-1, GIP, and glucagon) currently in Phase 2/3 clinical trials

Did you just start the medication

The clinical relevance of the study is primarily to show that diabetic patients responded to DPPIV-inhibitors differently with regards to its clinical effectiveness

Iron overload may also deplete both GSH (reduced glutathione) and methyl donors, which are required for maintaining normal DNA methylation patterns (Ye et al., 2019), which could indirectly alter neurotransmission signaling pathways, thereby influencing mood and behavior

Evening semaglutide dosing aligns peak nausea (48 hours post-injection) with sleep, significantly improving tolerability compared to morning administration